As cases of Cannabis Hyperemesis Syndrome (CHS) continue to rise, the National Organization for the Reform of Marijuana Laws (NORML) has released a detailed fact sheet addressing this condition, which has sparked increasing concern among both medical professionals and cannabis users.
Cal NORML, the California chapter of NORML, issued the fact sheet to shed light on the growing prevalence of CHS, particularly among long-term cannabis users who consume high doses of THC. Written by Cal NORML director Dr. Dale Gieringer, the fact sheet provides vital information on the symptoms, causes, and treatment of CHS, while urging consumers to be more cautious about chronic cannabis consumption.
What is Cannabis Hyperemesis Syndrome?
Cannabis Hyperemesis Syndrome is a relatively rare condition that is typically seen in individuals who use cannabis heavily over extended periods—months or even years. The syndrome is marked by cyclical episodes of severe nausea, vomiting, and abdominal pain, which may appear intermittently in regular cannabis users. While these symptoms may seem familiar to many cannabis consumers, who occasionally experience nausea or discomfort after using cannabis, CHS is a much more severe and chronic disorder.
Initially, many individuals experiencing CHS may attempt to treat their symptoms by using more cannabis, believing it will alleviate their nausea. Unfortunately, as Dr. Gieringer explains, this only worsens the problem. The only known effective remedy for CHS is to stop using cannabis altogether. Abstaining from cannabis, especially high-THC products like dabs, infused pre-rolls, and concentrates, is the primary method of halting the cycle of nausea and vomiting.
CHS vs. Cyclic Vomiting Syndrome (CVS)
One of the challenges in diagnosing CHS is that it shares symptoms with another condition known as cyclic vomiting syndrome (CVS). Both CHS and CVS cause nausea, vomiting, and abdominal pain. However, the key difference lies in the cause: CHS is directly linked to chronic cannabis use, while CVS is not. This overlap in symptoms can make it difficult to distinguish between the two conditions, especially since many individuals with CVS use cannabis to treat their symptoms.
Dr. Gieringer warns that if a person continues to experience symptoms after ceasing cannabis use, it could suggest the presence of a medical condition unrelated to CHS. Therefore, it’s crucial for individuals who suffer from these symptoms to seek medical attention and consider all potential underlying causes.
Why the Rise in Cases?
The fact sheet from Cal NORML comes amid reports that CHS cases are on the rise, coinciding with the increasing popularity and availability of high-potency cannabis products. Concentrates, dabs, and other THC-rich products are becoming more common among cannabis users, particularly among those who consume cannabis regularly. These products are much more potent than traditional flower, containing up to 90% THC compared to 15-20% in regular cannabis, which may contribute to the onset of CHS in some individuals.
Experts believe that while not everyone who uses THC-rich cannabis will develop CHS, those who use it in large quantities over time are at a higher risk. This is especially true for individuals who consume cannabis multiple times a day, which is becoming more common among habitual users.
Advice for Cannabis Consumers
For cannabis users, the takeaway from Cal NORML’s fact sheet is clear: moderation is key. Overuse of high-THC cannabis products should be avoided, especially for those who have been using cannabis for an extended period. If a consumer begins to experience episodic attacks of nausea, vomiting, and abdominal discomfort, it’s essential to stop using cannabis altogether, at least temporarily, and see if the symptoms improve.
Dr. Gieringer’s advice echoes this message: “If you’re experiencing these symptoms, try abstaining from cannabis rather than escalating your consumption. Many consumers make the mistake of thinking that consuming more cannabis will relieve their symptoms, but this only perpetuates the cycle of nausea and vomiting.”
Ongoing Research on CHS
In response to growing concerns, the University of California at Irvine is currently conducting a survey on CHS to better understand the condition and its effects. Cannabis consumers who are interested in contributing to this research can apply to participate, helping to advance scientific knowledge about this condition and improve treatment options.
As more research is conducted, it’s expected that healthcare professionals will become better equipped to diagnose and treat CHS. In the meantime, the public’s awareness of the syndrome—and the potential dangers of overconsuming THC—is critical.
The Role of Cal NORML in Cannabis Health Advocacy
Founded in 1972, Cal NORML has long been an advocate for the rights and well-being of cannabis users in California. Known for its pioneering research on cannabis vaporization and regular health warnings to its members, Cal NORML has been at the forefront of educating the public about the risks and benefits of cannabis use. The release of this fact sheet on CHS is part of their ongoing effort to ensure that cannabis consumers are informed and make safe choices regarding their health.
As cannabis use continues to rise across the United States, it’s vital that consumers remain aware of the potential health risks associated with chronic, heavy use. Cal NORML’s fact sheet serves as an essential tool in promoting public health and safety, while also encouraging consumers to approach cannabis with caution and responsibility.
David Johnson is a respected writer known for his expertise in crafting compelling articles about cannabis. With a passion for exploring the intersection of cannabis, health, and wellness, he sheds light on the therapeutic properties and potential uses of this versatile plant. David’s in-depth analysis and thought-provoking commentary offer readers a deeper understanding of the evolving landscape of cannabis legislation, consumption methods, and industry trends.
